{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T10:45:05Z","timestamp":1794998705749,"version":"4.9.1"},"reference-count":22,"publisher":"Oxford University Press (OUP)","issue":"10","license":[{"start":{"date-parts":[[2022,3,8]],"date-time":"2022-03-08T00:00:00Z","timestamp":1646697600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"DOI":"10.13039\/100015661","name":"UCB pharma","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015661","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,10,6]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Objectives<\/jats:title>\n                  <jats:p>Transplacental passage of certain biologic and targeted synthetic DMARDs leads to detectable levels in the neonate, which may impact on the safety of live vaccines. Guidelines advise delaying live vaccine administration in biologic-exposed infants until they are 7\u2009months old.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>A systematic review of Embase, Medline and Cochrane identified live vaccine outcomes in infants exposed to biologic or targeted synthetic DMARDs in utero.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Studies included 276 in utero exposures to adalimumab, certolizumab, etanercept, infliximab, golimumab, tocilizumab and ustekinumab. Live vaccine exposures at &amp;lt;12\u2009months of age included Bacille Calmette-Gu\u00e9rin (BCG) (n\u2009=\u2009215), rotavirus (n\u2009=\u200946), and measles, mumps and rubella (MMR) (n\u2009=\u200912). We identified no reactions following MMR, seven mild reactions to rotavirus vaccination and eight reactions to BCG, including one death. All infants with an adverse reaction to BCG had been exposed to infliximab in utero, and six had received BCG in the first month of life. A freedom of information request to the Medicines and Healthcare products Regulatory Agency revealed four fatal disseminated BCG infections in infants exposed to TNF inhibitors in utero, including infliximab, adalimumab and one unspecified TNF inhibitor.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>Most evidence for a clinically harmful effect was for early administration of the BCG vaccine to infants exposed in utero to TNF inhibitors with high transplacental transfer rates.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/rheumatology\/keac141","type":"journal-article","created":{"date-parts":[[2022,3,5]],"date-time":"2022-03-05T04:23:54Z","timestamp":1646454234000},"page":"3902-3906","source":"Crossref","is-referenced-by-count":53,"title":["A systematic review of live vaccine outcomes in infants exposed to\u00a0biologic disease modifying anti-rheumatic drugs <i>in utero<\/i>"],"prefix":"10.1093","volume":"61","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9701-190X","authenticated-orcid":false,"given":"Bethan","family":"Goulden","sequence":"first","affiliation":[{"name":"Department of Rheumatology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Chua","sequence":"additional","affiliation":[{"name":"General Medicine Department, University College London Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elaine","family":"Parker","sequence":"additional","affiliation":[{"name":"General Medicine Department, University College London Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian","family":"Giles","sequence":"additional","affiliation":[{"name":"Centre for Rheumatology, Department of Inflammation, Division of Medicine, University College London , London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2022,3,8]]},"reference":[{"key":"2022100812090925600_keac141-B1","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1093\/rheumatology\/kev404","article-title":"BSR and BHPR guideline on prescribing drugs in pregnancy and breastfeeding\u2014Part I: standard and biologic disease modifying anti-rheumatic drugs and corticosteroids","volume":"55","author":"Flint","year":"2016","journal-title":"Rheumatology (Oxford)"},{"key":"2022100812090925600_keac141-B2","author":"UK Immunisation Schedule: The Green Book, chapter 11"},{"key":"2022100812090925600_keac141-B3","author":"Rotavirus: The Green Book"},{"key":"2022100812090925600_keac141-B4","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/j.crohns.2010.05.001","article-title":"Case report: fatal case of disseminated BCG infection in an infant born to a mother taking infliximab for Crohn\u2019s disease","volume":"4","author":"Cheent","year":"2010","journal-title":"J Crohns Colitis"},{"key":"2022100812090925600_keac141-B5","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1136\/annrheumdis-2021-221036","article-title":"Analysing cord blood levels of TNF inhibitors to validate the EULAR points to consider for TNF inhibitor use during pregnancy","volume":"81","author":"Ghalandari","year":"2022","journal-title":"Ann Rheum Dis"},{"key":"2022100812090925600_keac141-B6","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1002\/acr.24130","article-title":"2020 American College of Rheumatology guideline for the management of reproductive health in rheumatic and musculoskeletal diseases","volume":"72","author":"Sammaritano","year":"2020","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"2022100812090925600_keac141-B7","author":"Contraindications and Special Considerations: The Green Book"},{"key":"2022100812090925600_keac141-B8","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1097\/01.MIB.0000440984.86659.4f","article-title":"Impact of anti-tumor necrosis factor alpha antibodies administered to pregnant women with inflammatory bowel disease on long-term outcome of exposed children","volume":"20","author":"Bortlik","year":"2014","journal-title":"Inflamm Bowel Dis"},{"key":"2022100812090925600_keac141-B9","doi-asserted-by":"crossref","first-page":"237","DOI":"10.5217\/ir.2018.00071","article-title":"Influence of anti-tumor necrosis factor-alpha therapy to pregnant inflammatory bowel disease women and their children\u2019s immunity","volume":"17","author":"Lee","year":"2019","journal-title":"Intest Res"},{"key":"2022100812090925600_keac141-B10","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1111\/apt.15504","article-title":"Safety of first year vaccination in children born to mothers with inflammatory bowel disease and exposed in utero to anti-TNF\u03b1 agents: a French nationwide population-based cohort","volume":"50","author":"Luu","year":"2019","journal-title":"Aliment Pharmacol Ther"},{"key":"2022100812090925600_keac141-B11","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1093\/rheumatology\/key091","article-title":"Tocilizumab concentrations in maternal serum and breast milk during breastfeeding and a safety assessment in infants: a case study","volume":"57","author":"Saito","year":"2018","journal-title":"Rheumatology (Oxford)"},{"key":"2022100812090925600_keac141-B12","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.cgh.2017.08.041","article-title":"Use of biologic therapy by pregnant women with inflammatory bowel disease does not affect infant response to vaccines","volume":"16","author":"Beaulieu","year":"2018","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2022100812090925600_keac141-B13","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1093\/rheumatology\/kez155","article-title":"Placental transfer of tocilizumab in a patient with rheumatoid arthritis","volume":"58","author":"Tada","year":"2019","journal-title":"Rheumatology (Oxford)"},{"key":"2022100812090925600_keac141-B14","doi-asserted-by":"crossref","first-page":"e14420","DOI":"10.1111\/dth.14420","article-title":"Use of biologic therapies for psoriasis during pregnancy and long-term outcomes of exposed children: a 14-year real-life experience at a tertiary center in Turkey and review of the literature","volume":"33","author":"Babuna Kobaner","year":"2020","journal-title":"Dermatol Ther"},{"key":"2022100812090925600_keac141-B15","doi-asserted-by":"crossref","first-page":"105","DOI":"10.55563\/clinexprheumatol\/j9ysbm","article-title":"Efficacy and safety of certolizumab pegol in pregnant women with uveitis. Recommendations on the management with immunosuppressive and biologic therapies in uveitis during pregnancy","volume":"39","author":"Prieto-Pe\u00f1a","year":"2021","journal-title":"Clin Exp Rheumatol"},{"key":"2022100812090925600_keac141-B16","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.1093\/ecco-jcc\/jjaa099","article-title":"Safety and optimal timing of BCG vaccination in infants born to mothers receiving anti-TNF therapy for inflammatory bowel disease","volume":"14","author":"Park","year":"2020","journal-title":"J Crohns Colitis"},{"key":"2022100812090925600_keac141-B17","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.3389\/fimmu.2017.01294","article-title":"Factors affecting the FcRn-mediated transplacental transfer of antibodies and implications for vaccination in pregnancy","volume":"8","author":"Wilcox","year":"2017","journal-title":"Front Immunol"},{"key":"2022100812090925600_keac141-B18","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.4049\/jimmunol.0903296","article-title":"Importance of neonatal FcR in regulating the serum half-life of therapeutic proteins containing the Fc domain of human IgG1: a comparative study of the affinity of monoclonal antibodies and Fc-fusion proteins to human neonatal FcR","volume":"184","author":"Suzuki","year":"2010","journal-title":"J Immunol"},{"key":"2022100812090925600_keac141-B19","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1053\/j.gastro.2016.04.002","article-title":"Concentrations of adalimumab and infliximab in mothers and newborns, and effects on infection","volume":"151","author":"Julsgaard","year":"2016","journal-title":"Gastroenterology"},{"key":"2022100812090925600_keac141-B20","author":"Rotavirus: Laboratory Confirmed Cases of Rotavirus Infections in England and Wales"},{"key":"2022100812090925600_keac141-B21","author":"Tuberculosis: The Green Book, chapter 32"},{"key":"2022100812090925600_keac141-B22","author":"BCG Vaccine AJV \u2013 Summary of Product Characteristics (SmPC) - (emc) n.d"}],"container-title":["Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/rheumatology\/advance-article-pdf\/doi\/10.1093\/rheumatology\/keac141\/43349639\/keac141.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/61\/10\/3902\/46382850\/keac141.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/61\/10\/3902\/46382850\/keac141.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,8]],"date-time":"2022-10-08T12:12:58Z","timestamp":1665231178000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/rheumatology\/article\/61\/10\/3902\/6544571"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,8]]},"references-count":22,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2022,3,8]]},"published-print":{"date-parts":[[2022,10,6]]}},"URL":"https:\/\/doi.org\/10.1093\/rheumatology\/keac141","relation":{},"ISSN":["1462-0324","1462-0332"],"issn-type":[{"value":"1462-0324","type":"print"},{"value":"1462-0332","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,10,1]]},"published":{"date-parts":[[2022,3,8]]}}}